A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) (DSS)
A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)
Sponsor: MCRA
Terminated
FDA reclassified so all 522 studies were stopped,
Listed as NCT01461005, this NA trial focuses on Kyphosis and Neurologic Deficits and remains terminated or withdrawn. Sponsored by MCRA, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Nov 2022 [monthly]
Terminated NA
-
Mar 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Nov 2019 — Mar 2020 [monthly]
Terminated NA
-
Nov 2018 — Nov 2019 [monthly]
Terminated NA
Status: Completed → Terminated
-
Jun 2018 — Nov 2018 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MCRA
- Paradigm Spine
For direct contact, visit the study record on ClinicalTrials.gov .